Evidence map›Paper›PMID 37626397›Full record

ArticleBMC psychology2023

Investigating two mobile just-in-time adaptive interventions to foster psychological resilience: research protocol of the DynaM-INT study.

S A Bögemann, A Riepenhausen, L M C Puhlmann, S Bar, E J C Hermsen, J Mituniewicz, Z C Reppmann, A Uściƚko, J M C van Leeuwen, C Wackerhagen and 23 more

Open access · goldAbstract read
In one paragraph

Article in BMC psychology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

33 authors at 14 institutions in 7 countries.

S A Bögemann *Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Kapittelweg 29, Nijmegen, 6525 EN, The Netherlands. sophie.bogemann@donders.ru.nl.ORCID http://orcid.org/0000-0001-9382-0769
A Riepenhausen *Research Division of Mind and Brain, Department of Psychiatry and Neurosciences CCM, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, and Berlin Institute of Health, Berlin, Germany.
L M C Puhlmann *Leibniz Institute for Resilience Research (LIR), Mainz, Germany.
S BarSagol Brain Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
E J C HermsenDonders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Kapittelweg 29, Nijmegen, 6525 EN, The Netherlands.
J MituniewiczFaculty of Psychology, University of Warsaw, Warsaw, Poland.
Z C ReppmannResearch Division of Mind and Brain, Department of Psychiatry and Neurosciences CCM, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, and Berlin Institute of Health, Berlin, Germany.
A UściƚkoFaculty of Psychology, University of Warsaw, Warsaw, Poland.
J M C van LeeuwenDonders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Kapittelweg 29, Nijmegen, 6525 EN, The Netherlands.
C WackerhagenResearch Division of Mind and Brain, Department of Psychiatry and Neurosciences CCM, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, and Berlin Institute of Health, Berlin, Germany.
K S L YuenLeibniz Institute for Resilience Research (LIR), Mainz, Germany.
M ZerbanNeuroimaging Center (NIC), Focus Program Translational Neuroscience (FTN), Johannes Gutenberg University Medical Center, Mainz, Germany.
J WeermeijerCenter for Contextual Psychiatry, Department of Neurosciences, KU Leuven, Louvain, Belgium.
M A MarciniakDivision of Experimental Psychopathology and Psychotherapy, Department of Psychology, University of Zurich, Zurich, Switzerland.
N MorSagol Brain Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
A van KraaijOnePlanet Research Center, Wageningen, The Netherlands.
G KöberInstitute of Medical Biometry and Statistics, Faculty of Medicine and Medical Center, University of Freiburg, Freiburg, Germany.
S PoosehFreiburg Center for Data Analysis and Modelling, University of Freiburg, Freiburg, Germany.
P KovalMelbourne School of Psychological Sciences, The University of Melbourne, Vic, 3010, Australia.
A Arias-VásquezDonders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Kapittelweg 29, Nijmegen, 6525 EN, The Netherlands.
H BinderInstitute of Medical Biometry and Statistics, Faculty of Medicine and Medical Center, University of Freiburg, Freiburg, Germany.
W De RaedtLife Sciences Department, Imec, Louvain, Belgium.
B KleimDivision of Experimental Psychopathology and Psychotherapy, Department of Psychology, University of Zurich, Zurich, Switzerland.
I Myin-GermeysCenter for Contextual Psychiatry, Department of Neurosciences, KU Leuven, Louvain, Belgium.
K RoelofsCenter for Cognitive Neuroimaging, Donders Institute for Brain Cognition and Behaviour, Radboud University, Nijmegen, The Netherlands.
J TimmerFreiburg Center for Data Analysis and Modelling, University of Freiburg, Freiburg, Germany.
O TüscherLeibniz Institute for Resilience Research (LIR), Mainz, Germany.
T Hendler *Sagol Brain Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
D Kobylińska *Faculty of Psychology, University of Warsaw, Warsaw, Poland.
I M Veer *Department of Developmental Psychology, University of Amsterdam, Amsterdam, The Netherlands.
R Kalisch *Leibniz Institute for Resilience Research (LIR), Mainz, Germany.
E J Hermans *Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Kapittelweg 29, Nijmegen, 6525 EN, The Netherlands.
H Walter *Research Division of Mind and Brain, Department of Psychiatry and Neurosciences CCM, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Radboud University Nijmegen · NLJohannes Gutenberg University Mainz · DEUniversity of Freiburg · DEUniversity of Warsaw · PLFreie Universität Berlin · DEHumboldt-Universität zu Berlin · DEKU Leuven · BETel Aviv University · ILUniversity of Zurich · CHIMEC · BELeibniz Institute for Resilience Research · DETel Aviv Sourasky Medical Center · ILThe University of Melbourne · AUUniversity of Amsterdam · NL

Funding

Deutsche Forschungsgemeinschaft DFG Grant CRC 1193, subprojects B01, C01, C04, Z03European Union's Horizon 2020 research and innovation program 777084German Federal Ministry for Education and Research (BMBF) as part of the Network for University Medicine 01KX2021State of Rhineland-Palatinate, Germany MARP program, DRZ program, Leibniz Institute for Resilience Research
6 · The paper itself

Abstract

backgroundStress-related disorders such as anxiety and depression are highly prevalent and cause a tremendous burden for affected individuals and society. In order to improve prevention strategies, knowledge regarding resilience mechanisms and ways to boost them is highly needed. In the Dynamic Modelling of Resilience - interventional multicenter study (DynaM-INT), we will conduct a large-scale feasibility and preliminary efficacy test for two mobile- and wearable-based just-in-time adaptive interventions (JITAIs), designed to target putative resilience mechanisms. Deep participant phenotyping at baseline serves to identify individual predictors for intervention success in terms of target engagement and stress resilience.

methodsDynaM-INT aims to recruit N = 250 healthy but vulnerable young adults in the transition phase between adolescence and adulthood (18-27 years) across five research sites (Berlin, Mainz, Nijmegen, Tel Aviv, and Warsaw). Participants are included if they report at least three negative burdensome past life events and show increased levels of internalizing symptoms while not being affected by any major mental disorder. Participants are characterized in a multimodal baseline phase, which includes neuropsychological tests, neuroimaging, bio-samples, sociodemographic and psychological questionnaires, a video-recorded interview, as well as ecological momentary assessments (EMA) and ecological physiological assessments (EPA). Subsequently, participants are randomly assigned to one of two ecological momentary interventions (EMIs), targeting either positive cognitive reappraisal or reward sensitivity. During the following intervention phase, participants' stress responses are tracked using EMA and EPA, and JITAIs are triggered if an individually calibrated stress threshold is crossed. In a three-month-long follow-up phase, parts of the baseline characterization phase are repeated. Throughout the entire study, stressor exposure and mental health are regularly monitored to calculate stressor reactivity as a proxy for outcome resilience. The online monitoring questionnaires and the repetition of the baseline questionnaires also serve to assess target engagement. DISCUSSION: The DynaM-INT study intends to advance the field of resilience research by feasibility-testing two new mechanistically targeted JITAIs that aim at increasing individual stress resilience and identifying predictors for successful intervention response. Determining these predictors is an important step toward future randomized controlled trials to establish the efficacy of these interventions.

Indexed as

Resilience, PsychologicalAdolescentAnxietyAnxiety DisordersHealth StatusHumansMental HealthMulticenter Studies as TopicRandomized Controlled Trials as TopicYoung AdultEcological momentary assessmentEcological momentary interventionLongitudinalMental healthMental imageryProspectiveReappraisalResilienceResilience factorsStress

Identifiers

PMID37626397
PMCPMC10464364
OpenAlexW4386161468

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.